link to RWJMS home page
Banner Image Here

Faculty

 Nandini Moorthy, M.D.

 Division Chief

 Associate Professor of Pediatrics

 E-mail: moorthln@rwjms.rutgers.edu

 Phone: 732-235-4980

 

 

 

The Bristol-Myers Squibb Pediatric Rheumatology Center of excellence headed by Dr. Lakshmi Nandini Moorthy at Robert Wood Johnson Medical School is a state-of-the-art family-friendly medical center. Pediatric rheumatic diseases comprise a complex array of chronic diseases with fluctuating courses that often are challenging to diagnose and manage. The center is focusing on diagnoses and management of complex rheumatic diseases including: Juvenile rheumatoid arthritis, Systemic Lupus Erythematosus, Mixed Connective Tissue Disease, Spondyloarthropathy Hypermobility Disorders, Reactive arthritis, Polymyositis, Juvenile Dermatomyositis, Vasculitides, Systemic sclerosis, Linear Scleroderma and morphea, Fibromyalgia, Periodic Fever Syndromes, and  Regional Musculoskeletal Pain Syndromes.  These diseases often lead to significant morbidity in children, disability that may be permanent and can potentially affect different aspects of growth, development and quality of life. Early diagnosis is essential to properly manage these children to prevent long-term complications. There is a critical need to develop a comprehensive clinical center for children with rheumatic diseases in New Jersey. This center will provide diagnosis, education, treatment and follow-up for children with various rheumatic diseases

In addition to clinical care, Dr. Moorthy has set up pediatric rheumatology rotations for medical students,      pediatric residents and adult rheumatology fellows. In addition, she collaborates with Rutgers University          work-study program to offer experience to undergraduate students as well. Dr. Moorthy has given over            35     talks    for CME credit and has organized three well-attended pediatric rheumatology symposiums for the         practitioners.  She has received the American College of Rheumatology visiting professor award in                Pediatric Rheumatology in 2009.

Dr. Moorthy’s primary research interest is in quality of life and physical functioning outcomes in pediatric           lupus. Specifically, she has developed and validated a new outcome instrument used for measuring health-related quality of life in children with lupus called, Simple Measure of the Impact of Lupus Erythematosus in Youngstersã (SMILEYã). She has been the recipient of the Arthritis Foundation Fellowship Award, UMDNJ Foundation Award and the Pfizer Clinical Scholar’s Grants and the Arthritis Foundation Clinical Investigator Award.  She is currently conducting a multinational study on cross-cultural validation of SMILEYã, which involves over 50 institutions across the world. Already her work has resulted in publications in excellent peer reviewed journals and several presentations at national and international conferences.  

Dr. Moorthy is currently board certified in Pediatrics and Pediatric Rheumatology, a fellow member of the American Academy of Pediatrics (AAP) (national and NJ chapter), member of the American College of Rheumatology (ACR), Childhood Arthritis and Rheumatology Research Alliance (CARRA), Eastern Society of Pediatric Research, Pediatric Rheumatology European Society, New York Academy of Sciences and the Arthritis Foundation. She is the co-editor of the AAP pediatrics rheumatology section newsletter and a member of the ACR Pediatric Residency Committee. She reviews for several peer reviewed journals. She is actively involved in community-related activities in conjunction with the Arthritis Foundation.

 

 

  Daniel Horton, MD, MSCE

  Assistant Professor of Pediatrics

  E-mail: adb177@rwjms.rutgers.edu

  Phone: 732-235-4980

 

 

 

 

 

Daniel Horton, MD, MSCE joined the Department of Pediatrics in the Division of Pediatric Rheumatology

as an Assistant Professor in August 2016. He is also a core faculty member of the Institute for Health,

Health Care Policy and Aging Research as well as an Assistant Professor of Epidemiology at the Rutgers

School of Public Health.

 

He is a graduate of Harvard Medical School and completed pediatrics residency at the Children's

Hospital of Philadelphia and pediatric rheumatology fellowship at Nemours/A.I. duPont Hospital for

Children. He received a Master of Science in Clinical Epidemiology degree at the University of Pennsylvania,

where he focused on the study of drug uses and effects in large populations.

 

He performs research on the utilization, safety, and effectiveness of medications in children as well as the

origins of childhood arthritis. He is currently funded by grants from the National Institutes of Health

and the Childhood Arthritis and Rheumatology Research Alliance.

 

He enjoys working with young people with chronic illnesses and their families and is committed to researching questions that will improve their lives.

 

 

Research projects include:

Drugs, Germs, & Joints: Antibiotics, Gut Microbiota, & Juvenile Idiopathic Arthritis, a project to better understand what causes and affects the activity of juvenile idiopathic arthritis.                                                                              Funding: National Institutes of  Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases

Stopping medicines for juvenile idiopathic arthritis: perspectives of patients and families, a study to identify the factors most important to patients with juvenile idiopathic arthritis and their parents in determining when to      stop medications. Funding: Childhood Arthritis and Rheumatology ResearchAlliance

Selected publications include:

  • Horton DB, Gerhard T, Davidow A, Strom BL. Impact of the black triangle label on prescribing of new drugs       in the United Kingdom: lessons for the United States at a time of deregulation. Pharmacoepidemiology          and Drug Safety; 2017, Aug 31. doi: 10.1002/pds.4304. [Epub ahead of print]
  • Morgan, EM, Riebschleger M, Horonjeff J, Consolaro A, Munro J, Thornhill S, Beukelman T, Brunner H,             Creek EL, Harris JG, Horton DB, Lovell DJ, Mannion, M, Olson JC, Rahimi H, Gallo MC, Calandra S, Ravelli A, Ringold S, Shenoi S, Stinson J, Toupin-April K, Strand V, Bingham III CO. Evidence for updating the core      domain set of outcome measures for juvenile idiopathic arthritis: Report from a special interest group at OMERACT 2016. Journal of Rheumatology; 2017, Aug 15. doi: 10.3899/jrheum.161389. [Epub ahead of print]
  • Horton DB, Haynes K, Denburg MR, Thacker MM, Rose CD, Putt ME, Strom BL. Oral glucocorticoid use and osteonecrosis in children and adults with chronic inflammatory diseases: a population-based cohort study.    BMJ Open; 2017, 7: e016788.
  • Horton DB, Onel KB, Beukelman T, Ringold S. Attitudes and approaches for withdrawing drugs for children    with clinically inactive non-systemic JIA: a survey of the Childhood Arthritis and Rheumatology Research   Alliance. Journal of Rheumatology; 2016, 44(3): 352-60.
  • Eutsler E, Horton DB, Edelman M, Finked T, Averill LW. Musculoskeletal MRI Findings of Juvenile Localized Scleroderma. Pediatric Radiology; 2016, 47(4):442-9.
  • Yang Y, Huang J, Mis M, Estacion M, Macala L, Shah P, Schulman BR, Horton DB, Dib-Hajj SD, Waxman SG. Nav1.7-A1632G mutation from a family with inherited erythromelalgia: enhanced firing of dorsal root ganglia neurons evoked by thermal stimuli. Journal of Neuroscience; 2016, 36(28): 7511-22.
  • Horton DB, Strom BL, Putt ME, Rose CD, Sherry DD, Sammons JS. The epidemiology of Clostridium difficile infection-associated reactive arthritis (CDIAReA) in children: an underdiagnosed, potentially morbid        condition. JAMA Pediatrics. 2016, 170 (7): e160217, 2016. PMCID: PMC5069192.
  • Scott FI, Horton DB, Mamtani R, Haynes K, Goldberg DS, Lee DY, Lewis JD. Administration of antibiotics to children before age 2 years increases risk for childhood obesity. Gastroenterology. 2016, 151(1): 120-9,     2016. PMCID: PMC4924569.
  • Horton DB, Scott FI, Haynes K, Putt ME, Rose CD, Lewis JD, Strom BL. Antibiotic exposure, infection, and the development of pediatric psoriasis: a nested case-control study. JAMA Dermatology. 2016; 152(2):191-9. PMCID: PMC4749454.
  • Horton DB, Scott FI, Haynes K, Putt ME, Rose CD, Lewis JD, Strom BL. Antibiotic exposure and juvenile   idiopathic arthritis: a case-control study. Pediatrics. 2015; 136(2): e333-343. PMCID: PMC4516942.